About the Event
As cell and gene therapies continue to advance, so too do the regulatory frameworks that surround these products. Researchers and industry organisations can find navigating the regulatory guidelines a challenge as they endeavour to interpret legal and safety protocols, and seek to understand the geographical variations and unique challenges that exist in different regions, while facilitating product development.
In this BioBriefing, Duncan Mackay (Director, Regulatory Affairs, ERA Consulting) will take both seasoned tourists and novices alike on a guided tour of the established concepts, current regulatory landscapes, and more recent destinations being explored by product development teams in the cell and gene therapy space. Duncan will provide attendees with an insight into some of the trending hot topics in cell & gene therapies and will explore the opportunities and challenges that lie ahead for organisations in the industry.